Nonalcoholic fatty liver disease and liver transplantation.
about
Treating morbid obesity in cirrhosis: A quest of holy grailCardiovascular risk after orthotopic liver transplantation, a review of the literature and preliminary results of a prospective studyMetabolic syndrome after liver transplantation: preventable illness or common consequence?Serum complement C3f and fibrinopeptide A are potential novel diagnostic biomarkers for non-alcoholic fatty liver disease: a study in Qingdao Twins.Liver transplantation and non-alcoholic fatty liver disease.Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation.Endoplasmic reticulum stress is a mediator of posttransplant injury in severely steatotic liver allografts.Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery.Patients with NASH and cryptogenic cirrhosis are less likely than those with hepatitis C to receive liver transplants.Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.Donor graft steatosis influences immunity to hepatitis C virus and allograft outcome after liver transplantation.Increased risk of colorectal polyps in patients with non-alcoholic fatty liver disease undergoing liver transplant evaluationA comparison of survival and pathologic features of non-alcoholic steatohepatitis and hepatitis C virus patients with hepatocellular carcinoma.Complications associated with liver transplantation in the obese recipient.Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?Differential expression of lumican and fatty acid binding protein-1: new insights into the histologic spectrum of nonalcoholic fatty liver diseaseCurrent concepts in the evaluation of patients for liver transplantation.Successful Treatment of Rapid Onset, Symptomatic de novo Non-alcoholic Steatohepatitis Following Liver Transplantation: A Case Report.Ischemic preconditioning attenuates ischemia/reperfusion injury in rat steatotic liver: role of heme oxygenase-1-mediated autophagy.Recurrence of non-viral liver disease after orthotopic liver transplantation.Jewel of the seabed: sea cucumbers as nutritional and drug candidates.Long-term outcome after liver transplantation.Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.Outcomes in liver transplantation: does sex matter?Altered alkaline phosphatase activity in obese Zucker rats liver respect to lean Zucker and Wistar rats discussed in terms of all putative roles ascribed to the enzyme.Metabolic syndrome and non-alcoholic fatty liver disease after liver or kidney transplantation.Cirrhotic cardiomyopathy: Implications for liver transplantation.Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.Lower rates of receiving model for end-stage liver disease exception and longer time to transplant among nonalcoholic steatohepatitis hepatocellular carcinoma.Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes.Nonalcoholic fatty liver disease following liver transplantation.Hepatobiliary quiz-6 (2013).Pioglitazone: more than just an insulin sensitizer.Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice.Weight loss interventions for morbidly obese patients with compensated cirrhosis: a Markov decision analysis model.Impact of Subnormothermic Machine Perfusion Preservation in Severely Steatotic Rat Livers: A Detailed Assessment in an Isolated Setting.Resolution of donor non-alcoholic fatty liver disease following liver transplantation.The Effect of High-Mobility Group Box 1 in Rat Steatotic and Nonsteatotic Liver Transplantation From Donors After Brain Death.Tauroursodeoxycholic acid affects PPARγ and TLR4 in Steatotic liver transplantation.
P2860
Q26775811-EB79D37A-6667-42F2-AC60-A1F9E386D80DQ28074308-6DE2C49D-908A-4FC0-8E90-F106E37080EFQ28728729-CA0127FA-DE2B-4AA5-9FB1-8174E69C13B4Q34252854-57AACBD8-A09B-4E94-A3A1-DD5B6B11144AQ34499022-DA507BB4-25EE-42F3-88F0-73ACFBEACA97Q34646976-17CBAF60-F8BB-468B-9CDD-BF6D2B292F9AQ34667420-40C1677B-42EC-431B-A7E5-E482E1B38820Q35358141-0E32EF26-8A20-4E46-A69B-10D64B2B28A7Q35535285-FFA3514C-94FD-4ACC-B1B6-2846F36C22B4Q35562084-1395E2FA-509B-4F74-ADBA-D6F5FE2681E2Q35570778-CE3AF39C-EB44-4D3C-BDB7-A0233D80D704Q36062584-8C3B2085-5434-4478-9830-8453E5D67A3DQ36175047-1CCC8518-6DB1-4947-875D-529AF2C48CC8Q36456985-370AACE6-BEE3-412E-8237-EB6CE46BD551Q37141687-72E9F9E5-7103-453D-BA89-481E281EA4ADQ37171953-53FC24D7-3B56-47BF-9203-0999C91C0A66Q37346009-C04F5B6D-73DC-4A08-9569-89E39FABC66CQ37613128-CDB60B50-BFA5-47B6-97B1-072DF114A453Q37694640-0E95854F-265A-4CB4-9559-E67F37E7B2B2Q37833670-9A0183E9-04FC-4D79-8318-61E6DB6DAC93Q37965731-A66110C2-CB81-42B5-8EF7-B3CAF941300AQ38002368-BF3ABCA4-96ED-44A7-8C07-08083265AB38Q38192013-B60D8106-2F61-4BAC-AB61-5F5E791364C0Q38272589-D34D2D1A-6A26-4969-9413-2902FD68D087Q38313874-16BE4B2A-8A6A-406A-BD41-1A7AFBBC7C67Q38682089-EF8689F7-2A13-463A-AD38-9573531AB484Q39240722-C189833A-5495-4A73-B32D-9B05B92E0774Q39283211-54D80926-224C-4E34-B04B-2E99AF61ECC9Q39652155-1184338E-D33E-47C2-A941-3AA5C71274ABQ40012479-AE00C8E2-4FD1-4953-97A2-B42505469C5BQ40108169-EFF6BF2E-75CC-4FFB-8404-1B6CDA779C79Q40707333-A8FDB951-B104-4B5A-97C1-D24C8CE7382DQ41258370-059CD58A-A075-4950-8565-BBBFA2CCE6A5Q43119247-DA1D183C-5E79-4B02-8A51-43873ED6FE7AQ43513482-0F02DA70-028D-4DD3-A35E-2BCD95FD4330Q47218598-08BD6E35-7F1A-4D88-BBB7-4CA29F588224Q47257211-E91A70D0-E89E-40A2-BF11-BC357061E91BQ48245357-BC7899B7-1FB5-44BB-9F74-FDEE3EBBF9E1Q49101185-011D8375-C6FB-4381-B2E6-7DE5CC02441BQ50910081-948CE409-0C3D-47CD-836D-347C7E71E457
P2860
Nonalcoholic fatty liver disease and liver transplantation.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Nonalcoholic fatty liver disease and liver transplantation.
@ast
Nonalcoholic fatty liver disease and liver transplantation.
@en
type
label
Nonalcoholic fatty liver disease and liver transplantation.
@ast
Nonalcoholic fatty liver disease and liver transplantation.
@en
prefLabel
Nonalcoholic fatty liver disease and liver transplantation.
@ast
Nonalcoholic fatty liver disease and liver transplantation.
@en
P356
P1476
Nonalcoholic fatty liver disease and liver transplantation.
@en
P2093
Paul Angulo
P2860
P304
P356
10.1002/LT.20738
P577
2006-04-01T00:00:00Z